Making clinical trials equitable is one of the biggest challenges we face as an industry. We see this time and again, with one of the latest examples coming in the form of a study published in JAMA Network Open that found substantial underrepresentation of Black patients enrolled in pivotal trials for CAR-T therapy.
Women are another demographic negatively affected by inequality in clinical research. Earlier this month [May 2022] the American Heart Association issued a
Read More
Biotech
Non-Invasive, Precision-Based Approaches for Diagnosis and Treatment of Inflammatory Skin Conditions
Inflammatory skin conditions such as atopic dermatitis, psoriasis, vitiligo, hidradenitis suppurativa and others impact a significant portion of the U.S. population. In fact, nearly half of all visits to primary care physicians include some level of dermatological indication. Many of these dermatologic conditions are accompanied by pain and severe discomfort for affected patients, and the resulting morbidity of the condition may have a negative impact on mental health, self-esteem and overall
Read More
HLTH22 Day 2 News Summary: Amazon Clinic Launch, General Catalyst, Verizon, Higi
Amazon Launches Amazon Clinic Across 32 States
Amazon launches Amazon Clinic, a virtual care option that will operate across 32 states that offers up-front pricing, and treatment within hours, instead of days—helping customers achieve better health. Welcome to easy-to-use, effective care for common health conditions.
For customers, the cost of consultations will vary by provider and includes ongoing follow-up messages with their clinician for up to two weeks after the initial
Read More
Drug Price Transparency: Planning for Change
Currently, some 22 states have enacted prescription drug transparency laws that require entities across the drug supply chain to report pricing information to state officials. Designed to shed light on the true cost of drugs and to ensure that consumers and insurers aren’t being gouged, drug pricing transparency laws seek to level the playing field by delivering greater visibility into drug costs. And given the fact that prescription drug prices continue to increase, the topic of drug price
Read More
The Desire for Cost Savings Driving Key Trends in Healthcare Market
The healthcare market underwent significant changes during the pandemic as patients rethought how they received care, including opting for more telehealth and deferred elective procedures, but patient care is now normalizing as patients return to the office. However, payers are working to reduce the cost of care to reel in healthcare costs and keep premiums lower to remain competitive, driving key changes.
Ambulatory Surgery and Home Care
Surgeries are increasingly moving away from
Read More
ChristianaCare Spins Out New Gene Editing Company, CorriXR Therapeutics
What You Should Know:
- ChristianaCare recently announced it has spun out its first commercial biotechnology private startup company, named CorriXR Therapeutics. The company will use CRISPR gene editing technology to develop new, clinically relevant oncologic therapeutics in areas of unmet medical need, starting with squamous cell carcinoma of the lung. Its close relationship with ChristianaCare and the ChristianaCare Gene Editing Institute uniquely positions it to research and develop
Read More
Pleno Secures $40M to Disrupt Sequencing Market, Scale Multi-omics
What You Should Know:
- Pleno, Inc, a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research raises $40M in Series A funding led by Deerfield Management and Foresite Capital.
- The funding will accelerate the development of Pleno’s Hypercoding™ instrument platform, called RAPTOR ™, which is slated for early customer access in 2023 and full availability in 2024. Release below
Read More
Surge Raises $2.6M for Blood Test to Predict Post-Surgery Complications
What You Should Know:
- Biotech and medical AI innovator Surge announced a $2.6M round co-led by HCVC, a global early-stage fund dedicated to high-potential technology startups, and Boutique Venture Partners, a leading fund based in the Silicon Valley . Veteran angel investors, including Nicolas Godin, the COO/CFO of Cardiologs, also participated in the round.
- Based on an exclusive license to Stanford's patented postoperative complication prediction technology, Surge's flagship product
Read More
Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data
What You Should Know:
- Freenome, a privately held biotech company, today announced the launch of the Sanderson Study, the company’s latest study of its multiomics platform, in combination with real-world data to detect multiple cancers.
- The study will encompass both traditional and real-world data to generate evidence of clinical validation for certain high- and elevated-risk populations while also refining the platform’s cancer classification and risk prediction models. In addition,
Read More
H1 Launches AI-Powered and Evidence-Based Interactions
What You Should Know:
- H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams.
- New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement.
Establishing AI-Driven Efficient Workflows
H1 is
Read More
